Clinical performance evaluation of the Idylla NRAS-BRAF mutation test on retrospectively collected formalin-fixed paraffin-embedded colorectal cancer tissue
Journal of Clinical Pathology Sep 15, 2017
Johnston L, et al. - A research was conducted on the efficacy of Idylla NRAS-BRAF mutation test, for colorectal cancer. This test exhibited a high concordance with a widely used NRAS-BRAF test. Hence, it was discovered to be suitable for use as an in vitro diagnostic device for this application.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
